마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake

on

  • 1,000 views

 

Statistics

Views

Total Views
1,000
Views on SlideShare
960
Embed Views
40

Actions

Likes
1
Downloads
37
Comments
0

2 Embeds 40

http://blog.mothersafe.or.kr 38
http://www.hanrss.com 2

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

CC Attribution-NonCommercial-NoDerivs LicenseCC Attribution-NonCommercial-NoDerivs LicenseCC Attribution-NonCommercial-NoDerivs License

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake Presentation Transcript

  • 1. Dopamine Transporter inADHD & Alcohol intake Motherisk Round 2011. 11. 29 B.Y. Lee
  • 2. • Dopamine? - neurotransmitter? - reward system - related diseases• ADHD?• Alcohol? (pathway with dopamine)• ADHD- alcohol?• Dopamine – ADHD – alcohol?• Related reports - epigenetic, dopaminergic, …• Epigenetic project
  • 3. • Vesicle release process: docking → priming → fusion• Proteins involved in presynaptic exocytosis• SNARE proteins: docking (membs close together before fusion)• Synaptotagmin (vesicle protein) - Ca2+ sensor triggering fusion
  • 4. I. Small molecule NT ① acetylcholine ② Amino Acids • glutamate • GABA & glycine ③ Biogenic amines • dopamine, norepinephrine (noradrenalin), epinephrine (adrenalin), serotonin (5-hydroxy tryptamine, 5-HT), histamine ④ Purines: ATPII. Peptides • Substance P, CGRP(calcitonin gene related peptide), Enkephalin, Cholecystokinin(CCK), etc. • Opioid peptides • Substance PIII. Gaseous NT – Nitrous oxide, Carbon monoxide
  • 5. 1) Acetylcholine R ① Nicotinic: Ionotropic cys-loop superfamily ② Muscarinic: Metabotropic family R (M1~M5)2) Inhibitory amino acid R: Ionotropic (GABAA,C & Gly), metabotropic (GABAB)3) Excitatory amino acid R: Glutamate : NMDA, Kainate, AMPA4) Purine (ATP) R: Ionotropic (P2X) & metabotropic (P2Y), presyn adenosine-R5) Biogenic amine R: metabotropic except 5-HT3 (Ionotropic cys-loop superfamily)6) Neuropeptides R: metabotropic R, diffused extracellular NT, more sensitive7) Gas NT R: NO, CO - no binding to R, enzyme activation, modification of protein activity by nitrosylating
  • 6. Synthesis  Storage and release  Receptor binding  DegradationA. Release and degradation of the NT inside the axon terminalB. Increased NT release into the synapseC. Prevention of NT release into the synapseD. Inhibition of synthesis of the NTE. Reduced reuptake of the NT from the synapseF. Reduced degradation of the NT in the synapseG. Agonist (evoke same response as neurotransmitter) or antagonists (block response to neurotransmitter) can occupy the receptorsH. Reduced biochemical response inside the dendrite
  • 7. Amine Compounds: Serotonin, Noradrenalin and DopamineThese are the brain chemicals that to malfunction when stress levels becomemore than a person can handle
  • 8. Norepinephrine (NE)• noradrenergic neurons in the locus ceruleus and nucleus subceruleus• PNS: Smooth muscles, cardiac muscle and glands - Increase in blood pressure, constriction of arteries• CNS: General behaviorSerotonin (5-HT)• serotonergic neurons in the raphe nuclei• Regulation of mood, behavior, appetite, and cerebral circulation.• SSRIs (serotonin-specific reuptake inhibitors): – Inhibit reuptake and destruction of serotonin, prolonging the action of NT – Used as an antidepressant – Reduces appetite, treatment for anxiety, treatment for migraine headachesHistamine• Histaminergic neurons in tuberomammillary n. of hypothalamus Epinephrine• Adrenergic neurons in rostral medullaEpinephrine• Adrenergic neurons in rostral medulla
  • 9. Dopamine (DA) is a monoamine neurotransmitter that upon binding toa dopamine receptor (G-protein coupled) releases a variety of downstream signals.Where is dopamine formed/produced?Mainly in areas of the central and peripheral nervous systems, such as in thehypothalamus, the arcuate nucleus, and the caudad.What are the functions of dopamine?In the cardiovascular, renal, hormonal, and central nervous systems.To control processes as diverse asmovement to drug addiction.Dopamine dendrites extend intovarious regions of the brain,controlling different functions throughthe stimulation of α and β adrenergicand dopaminergic receptors (D1 and D2)(Velasco et al., 1998).
  • 10. DAT (The dopamine transporter)regulates the uptake of dopamineinto neurons.Dopamine is thought to bind to DTvia a separate binding domain thatis constructed of multiple aminoacid residues. These amino acidresidues are not present in theprimary structure of DT, but arethought to have interactions withthe protein in its tertiary form.MAO (monoamine oxidase)breaks down free dopamine(not contained in a vesicle).MAO play a role in recycling thecomponents of dopamine, but italso keeps the concentration ofdopamine lower than the rate atwhich it is being produced.
  • 11. • Dopaminergic neurons in the two main brainstem regions − substantia nigra pars compacta & ventral tegmental area (VTA) a. Nigrostriatal dopamine system: • Neurons in substantia nigra send fibers to corpus striatum. • Initiation of skeletal muscle movement. • Parkinson’s disease: degeneration of neurons in substantia nigra. b. Mesolimbic dopamine system: • Neurons originate in midbrain, send axons to limbic system. • Involved in behavior and reward. • Addictive drugs: promote activity in nucleus accumbens c. Meso-cortical pathway • negative symptoms (motivation and emotional response) d. Tubulo-infundibular pathway (endocrine related, prolactin)
  • 12. • The mesolimbic dopamine path correspond to the parts of the limbic system, which are connected to emotions and is responsible for the ability to learn, the short-term memory, maintenance of moods and the alignment of thought and action.• The mesolimbic system represents a modulation system, a filter and gating system for signals coming from the limbic system and for signals which maintain the basic functions of life and motivation (Koob 1992).• The Nucleus accumbens, - the most important end point of the mesolimbic dopamine path. - a clearing centre for signals coming from the limbic system - the switching point, which anticipates the probability of reward-stimuli and steers the attention of the nerve system.
  • 13. Mesolimbic Dopamine Pathway M-receptor D-receptor
  • 14. • Dopamine deficiency in the striatum or substantia nigra : Parkinson’s-like symptoms. - movement becomes slow and rigid, accompanied by muscle tremor. - L-DOPA have been created to supplement the quantity of dopamine in the brain (Katzenschlager et al., 2002).• An excessive amount of dopamine : Schizophrenia - characterized by altered behavior, and delusions. - Cocaine, block the return of dopamine into the brain, resulting in a build up of dopamine in the synapse, leading to drug-induced psychosis or schizophrenia. Tourett’s syndrome, ADHD
  • 15. • The most commonly dignosed neuropsyciatric disorder in child hood• ADHD wanes with age, symptoms can persist into adolescence and adulthood.• The incidence in children : 3% ~ >5% (Biederman 1998)• The diagnosis of ADHD : is currently based on DSM-IV criteria.• The core symptoms : impulsivity, inattention, motor restlessness• Heterogenous clinical symptoms, comorbidity (approx. 65%) with other disorders (conduct, mood, bipolar and anxiety disorders, Tourette’s)• Abnormal morphology and function of ADHD brains, detected primarily by magnetic resonance imaging, converge on the catecholamine-rich frontal cortex and subcortical neural networks
  • 16. • On the basis of the following lines of evidence, the DAT is one of several lead candidates for investigating the pathophysiology of ADHD and anti-ADHD drug mechanisms:1) dopamine transport inhibitors indirectly activate dopamine receptor subtypes; D4 and D5 dopamine receptors are implicated in ADHD, and dopamine receptor activity enhances attention and experiential salience and engenders stimulation2) the DAT is a selective and principal target of the most widely used antihyperactivity medications (amphetamine and methylphenidate)3) the DAT gene is associated with ADHD4) in some studies, abnormal levels of the DAT have been detected in brains of ADHD subjects.
  • 17. • Dopamine is released from both dendrites and axons and might activate receptors locally or remotely through volume transmission.• The DAT limits the duration of synaptic activity and diffusion by sequestering dopamine into neurons (Cragg and Rice 2004).• The DAT is present on cell bodies, dendrites, and axons but apparently is not localized in the immediate active zone of the synapse (Hersch et al 1997)• Accordingly, the DAT might reduce dopamine overflow into perisynaptic regions but not robustly sequester dopamine within the synapse.• Overexpression of the DAT might lead to compensatory increases in dopamine release, a reduction in extracellular dopamine levels, or altered cellular distribution of the DAT.
  • 18. Monoamine Neurotransmitter TransportersExtracellular neurotransmitter concentrations are regulated, in part, by monoaminetransporters that sequester dopamine (DAT), serotonin (SERT), and norepinephrine(NET) into neurons.The majority of specific genes implicated in ADHD encode components ofcatecholamine signaling systems.The critical role of monoamine transporters for normal brain function isunderscored by the wide range of drugs that target monoamine transporters,including medications for depression, ADHD, smoking addiction, obsessive-compulsive disorder, and sleep disorders.DAT is one of several genes implicated ADHD
  • 19. • DAT is a principal target of the most widely used antihyperactivity medications (amphetamine and methylphenidate).• All current anti-ADHD drugs modulate DA and NE levels in brain regions expressing DAT and NET. The majority of these drugs interfere with transporter-mediated clearance of extracellular neurotransmitters.• Interfere with DAT by brain-region- and drug-specific mechanisms  indirectly activating DA and possibly NE-R subtypes  raising extracellular DA levels in DAT- rich brain regions  enhancing attention and experiential salience.• Repeated use of certain transport inhibitors (cocaine…), can eventually result in compulsive drug-seeking behavior.
  • 20. • At the molecular level, the 12-membrane–spanning DAT protein contains a large extracellular loop, with consensus sites for glycosylation that function to regulate DAT trafficking and stability (Li et al 2004).• Similarly, glycosylation of the NET controls stability, trafficking, and transport activity (Melikian et al 1996). Potential phosphorylation sites (serine, threonine, and tyrosine) might also acutely modulate DAT trafficking.
  • 21. • A length or of sequence in the 3=-untranslated region of the DAT gene might affect DAT expression.• A fixed length–repeat sequence, by number of repeats from 3 to 11. 10 repeats sequences are the most common• Inheritance of this repeat length in both alleles is associated with ADHD in some studies but accounts for less than 4% of the variance.• Intragenic allelic interactions might distinguish haplotype functional diversity, and association studies might inadvertently group haplotypes of different function together on the basis of VNTR length. The DAT Gene Variants
  • 22. • DAT control of dopamine release is region specific. - In the striatum, dopamine clearance is a primary function of the DAT, whereas in the substantia nigra the DAT regulates extracellular dopamine levels by controlling both clearance and release.• The complexity of region-specific DAT function is relevant to the pharmacologic effects of anti-ADHD drugs.• Methylphenidate blocks dopamine transport, whereas amphetamine is a substrate for the DAT and presumably can trigger dopamine release in the substantia nigra. • These positron emission tomography (PET) scans show that patient with ADHD had lower levels of dopamine transporters in the nucleus accumbens , a part of the brains reward center, than control subjects
  • 23. Main Effects:• Alcohol mainly acts on GABAreceptors (GABA receptors downregulate the NT release of neurons,essentially reducing neural activity) bykeeping its Cl- receptors open longerthan they normally would be.• This causes GABA receptors to havean increased effect and reducesneural activity resulting in the calm,sleepy feeling.• Alcohol also inhibits glutamatereceptor function which causesslurred speech, memory deficits, anddiscoordintaion.
  • 24. Secondary Effects:• Raises the endorphin levels - causes the analgesic affect (pain killing).• Increases the amount of dopamine in the brain – contributes to the addictive qualities.
  • 25. • Can affect the methionine– homocysteine cycle by disrupting the enzymes required for methionine metabolism, thus interfering with SAM dependent methylation reactions.• Alcohol and its breakdown products (i.e., metabolites such as acetaldehyde) also cause different site specific modifications in histones.• Changes in the acetylation and methylation patterns of specific histones resulting from chronic alcohol feeding and high blood alcohol levels can lead to persistently altered gene expression and thus may play a role in this “epigenetic memory.”• May reduce the absorption of folate, a key component of the methionine– homocysteine cycle, thereby influencing methylation capacity.
  • 26. • During prenatal and early postnatal development, the epigenome is highly susceptible to environmental stimuli such as diet, drugs, environmental agents, and maternal behavior.• Preconception, preimplantation, and gastrulation - Appear to be particularly sensitive to the teratogenic effects of alcohol, - The clinical variability of FASD may be related not only to the dose of alcohol but also to when alcohol exposure occurs in relation to developmental periods.• Gastrulation appears to be most sensitive to teratogenic insults- a wide range of adverse effects (morphological and behavioral abnormalities)• Both preconception and preimplantation alcohol exposure can cause adverse effects, even though the embryo is not directly exposed to alcohol at this stage because it is not yet implanted in the uterus and therefore not connected to or nourished by the maternal system, probably provides the most compelling evidence of a role for epigenetic mechanisms in the outcomes observed.
  • 27. Maternal effect Paternal effect (preconceptional/(preconceptional) prenatal) - How long ? - How severe ? - Epigenetic target ? - DAT ? - SERT ? - MecP2 ?
  • 28. Thank you for your attention !